Literature DB >> 22901438

Neuroleptic treatments and overflow movements in schizophrenia: are they independent?

Elisa D'Agati1, Livia Casarelli, Mariabernarda Pitzianti, Augusto Pasini.   

Abstract

Neurological soft signs (NSS) are minor neurological abnormalities that can be revealed by a clinical examination focused on sensory and motor information processing. NSS include overflow movements (OMs), which are defined as involuntary movements that may accompany the production of voluntary movements. OM is generally considered to be a characteristic feature of schizophrenia. White matter abnormalities might be involved in the pathogenesis of OMs. Dopamine receptors play a role in oligodendrocytes development. There is a direct link between antipsychotic agents that bind to dopamine receptors on oligodendrocytes and the development of oligodendrocytes and myelin formation. In this paper, we review the current knowledge of the effects of antipsychotic agents on NSS in schizophrenic patients. As a result of this critical review we hypothesize that the neuroleptic actions described in this paper could explain why antipsychotic agents have no effect on the resolution of NSS in patients with schizophrenia.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901438     DOI: 10.1016/j.psychres.2012.07.049

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Social priming enhances interpersonal synchronization and feeling of connectedness towards schizophrenia patients.

Authors:  Stéphane Raffard; Robin N Salesse; Ludovic Marin; Jonathan Del-Monte; Richard C Schmidt; Manuel Varlet; Benoit G Bardy; Jean-Philippe Boulenger; Delphine Capdevielle
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

2.  Influence of facial feedback during a cooperative human-robot task in schizophrenia.

Authors:  Laura Cohen; Mahdi Khoramshahi; Robin N Salesse; Catherine Bortolon; Piotr Słowiński; Chao Zhai; Krasimira Tsaneva-Atanasova; Mario Di Bernardo; Delphine Capdevielle; Ludovic Marin; Richard C Schmidt; Benoit G Bardy; Aude Billard; Stéphane Raffard
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.